No definition available.
Inflammatory disorders of male genital organs, not elsewhere classified
EFO MESH Endpoint Browser PheWeb
N14_INFLAMALEGEN
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
497 |
4. Check minimum number of eventsNone |
497 |
5. Include endpointsNone |
497 |
6. Filter based on genotype QC (FinnGen only) |
497 |
Control definitions (FinnGen only)
- Control exclude
- N14_MALEGEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N40-N51
- Name in latin
- Morbositates inflammatoriae organorum genitalium masculinorum non alibi classificatae
Inflammatory disorders of male genital organs, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4288 | - | 4288 |
| Only index persons | 3668 | - | 3668 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | - | 0.12 |
| Only index persons | 0.14 | - | 0.14 |
| Median age at first event (years) | |||
| Whole population | - | - | 48.29 |
| Only index persons | - | - | 45.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 497 | - | 497 |
| Unadjusted period prevalence (%) | 0.22 | - | 0.22 |
| Median age at first event (years) | 54.10 | - | 54.10 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 448
- Matched controls
- 4479
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N49.2
ICD-10 Finland
Inflammatory disorders of scrotum
3156.5
204.5
182
*
N49.9
ICD-10 Finland
Inflammatory disorder of unspecified male genital organ
+∞
178.4
159
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
45.9
72.9
89
24
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
96.6
60.8
66
8
KFA40
NOMESCO Finland
Incision of scrotum
280.6
50.1
50
*
N40
ICD-10 Finland
Hyperplasia of prostate
6.4
46.8
140
296
6084A
ICD-9 Finland
Other disorders of male genital organs, Other inflammatory disorders of male genital organs
+∞
41.3
39
*
KED22
NOMESCO Finland
Transurethral resection of prostate
27.6
33.0
45
18
J01MA02
ATC
ciprofloxacin; systemic
3.5
32.2
216
947
QBA10
NOMESCO Finland
Incision of skin of trunk
36.4
31.5
40
12
N45.0
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis with abscess
+∞
29.5
28
*
60750
ICD-8 Finland
Other disease of male genital organs, Other inflammatory diseases
+∞
28.4
27
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
28.6
27.5
37
14
UKC02
NOMESCO Finland
Cystoscopy
4.6
26.2
100
262
XKD00
NOMESCO Finland
Uroflowmetry
4.4
24.8
99
270
KGH10
NOMESCO Finland
Operation for phimosis
49.6
23.6
28
6
N49.1
ICD-10 Finland
Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
+∞
23.1
22
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
11.8
22.7
42
39
KFD20
NOMESCO Finland
Excision of hydrocele of testis
+∞
22.1
21
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.9
21.6
98
299
N49.0
ICD-10 Finland
Inflammatory disorders of seminal vesicle
+∞
21.0
20
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
31.8
20.8
27
9
R33
ICD-10 Finland
Retention of urine
5.6
19.9
60
120
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
18.1
78
225
KFA00
NOMESCO Finland
Exploration of testis
187.1
17.6
18
*
N43.3
ICD-10 Finland
Hydrocele, unspecified
30.2
17.6
23
8
J01MA12
ATC
levofloxacin; systemic
3.0
16.1
102
395
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.9
15.9
54
123
G04CA02
ATC
tamsulosin; oral
2.5
15.9
154
770
L73.2
ICD-10 Finland
Hidradenitis suppurativa
34.8
15.9
20
6
J01FF01
ATC
clindamycin; systemic
2.6
15.4
139
667
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
15.3
134
628
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.0
15.1
63
176
N30.0
ICD-10 Finland
Acute cystitis
5.9
14.6
41
75
P01AB01
ATC
metronidazole; oral, rectal
2.4
14.6
152
781
J01EA01
ATC
trimethoprim; systemic
3.9
14.5
63
182
J01DB01
ATC
cefalexin; oral
2.4
14.4
355
2735
KFC00
NOMESCO Finland
Unilateral orchiectomy
20.0
14.4
21
11
N49.8
ICD-10 Finland
Inflammatory disorders of other specified male genital organs
+∞
13.6
13
*
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
6.7
13.5
34
54
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.9
13.4
44
97
R31
ICD-10 Finland
Unspecified haematuria
3.6
12.8
59
179
N02BE01
ATC
paracetamol; systemic, rectal
2.3
12.7
355
2794
N43.0
ICD-10 Finland
Encysted hydrocele
+∞
12.6
12
*
A46
ICD-10 Finland
Erysipelas
2.8
12.3
87
357
K60.3
ICD-10 Finland
Anal fistula
8.5
11.7
25
31
XJH00
NOMESCO Finland
Transanal ultrasonography
5.0
11.6
37
79
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
11.6
57
183
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
+∞
11.5
11
*
N48.1
ICD-10 Finland
Balanoposthitis
8.7
11.4
24
29
J01CA08
ATC
pivmecillinam; oral
4.7
11.3
38
86
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
36.0
11.3
14
*
S97
ICPC
Chronic ulcer skin
4.5
11.3
40
96
N43.4
ICD-10 Finland
Spermatocele
18.4
10.8
16
9
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.9
10.8
44
121
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.8
197
1265
ZZA00
NOMESCO Finland
Split skin graft
5.5
10.7
31
60
Y05
ICPC
Scrotum/testis sympt/compl other
12.4
10.4
18
15
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
6.5
10.3
26
42
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
10.3
126
684
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
10.1
114
595
SPAT1125
SPAT
Stoma care and guidance
11.0
9.9
18
17
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
2.8
9.8
64
248
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.0
9.7
56
201
R35
ICD-10 Finland
Polyuria
4.3
9.7
35
86
JHA00
NOMESCO Finland
Anal or perianal incision
7.4
9.6
22
31
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
9.5
58
215
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.6
9.5
27
51
S10
ICPC
Boil/carbuncle
4.2
9.5
35
88
KFH96
NOMESCO Finland
Other reconstructive operation on testis, epididymis or vas deferens
102.1
9.4
10
*
60740
ICD-8 Finland
Other disease of male genital organs, Seminal vesiculitis
+∞
9.4
9
*
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
+∞
9.4
9
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
9.0
9.4
19
22
C03CA01
ATC
furosemide; systemic
2.0
9.3
135
781
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
9.2
191
1261
N03AX16
ATC
pregabalin; oral
2.3
9.2
90
438
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.1
100
514
G04CB02
ATC
dutasteride; oral
3.9
9.1
37
102
S18
ICPC
Laceration/cut
1.9
9.0
172
1101
UJF32
NOMESCO Finland
Coloscopy
2.1
8.9
110
594
E0000UV
ATC
NA
2.0
8.8
151
926
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
8.7
38
111
N44
ICD-10 Finland
Torsion of testis
28.1
8.5
11
*
7502
FHL
Skrotum's incision revision or suturing
+∞
8.4
8
*
JFF23
NOMESCO Finland
Transversostomy
9.7
8.3
16
17
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.7
8.3
20
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.4
8.3
29
70
J01DA01
ATC
[U] cefalexin; systemic
1.8
8.2
255
1901
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
12.0
8.1
14
12
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
8.1
39
124
N05BA04
ATC
oxazepam; oral
2.2
8.1
93
486
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
8.0
145
902
B01AB05
ATC
enoxaparin; parenteral
2.0
7.9
113
642
A02BC02
ATC
pantoprazole; systemic
1.8
7.9
247
1837
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
7.8
74
352
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
45.8
7.7
9
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
7.6
63
278
K61.0
ICD-10 Finland
Anal abscess
5.6
7.6
21
39
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.3
7.6
19
31
N41.0
ICD-10 Finland
Acute prostatitis
10.3
7.6
14
14
SPAT1263
SPAT
Sampling
1.8
7.6
157
1021
N30.9
ICD-10 Finland
Cystitis, unspecified
6.2
7.5
19
32
N05AH04
ATC
quetiapine; oral
2.2
7.4
76
374
C07AB07
ATC
bisoprolol; oral
1.8
7.4
196
1375
J01FA06
ATC
roxithromycin; oral
1.8
7.4
149
957
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
7.0
7.4
17
25
M72.6
ICD-10 Finland
Necrotizing fasciitis
+∞
7.3
7
*
M54.5
ICD-10 Finland
Low back pain
1.9
7.3
120
718
J01AA02
ATC
doxycycline; systemic
1.7
7.3
296
2362
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
7.3
77
385
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.1
7.3
39
135
N41.1
ICD-10 Finland
Chronic prostatitis
7.5
7.2
16
22
B03XA02
ATC
darbepoetin alfa; parenteral
6.2
7.1
18
30
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.1
119
717
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.1
65
305
ZXA05
NOMESCO Finland
Left side
1.9
7.1
107
621
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
5.1
7.1
21
43
WX320
NOMESCO Finland
Spinalanesthesy
2.1
7.0
82
430
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.2
7.0
25
62
A28
ICPC
Limited function/disability NOS
2.4
7.0
60
273
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.0
57
252
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.8
35
118
L03.9
ICD-10 Finland
Cellulitis, unspecified
6.0
6.7
17
29
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.1
6.7
34
114
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.9
6.6
110
658
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
12.5
6.6
11
9
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.3
6.5
16
26
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.6
6.4
27
78
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
6.4
40
151
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.4
6.3
21
49
KED33
NOMESCO Finland
Transurethral incision of prostate
18.3
6.3
9
5
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
+∞
6.3
6
*
N48.6
ICD-10 Finland
Induratio penis plastica
+∞
6.3
6
*
QBE05
NOMESCO Finland
Excision of sweat glands or sweat gland bearing skin from trunk
+∞
6.3
6
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
6.3
31
102
R53
ICD-10 Finland
Malaise and fatigue
2.1
6.3
73
383
A48.0
ICD-10 Finland
Gas gangrene
27.1
6.2
8
*
7451
FHL
Transurethral adenoma removal
27.1
6.2
8
*
G04CA52
ATC
tamsulosin and dutasteride; systemic
2.5
6.2
47
200
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.4
6.2
15
24
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
6.2
113
698
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
6.2
31
103
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
6.2
32
109
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
6.1
39
149
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
6.1
144
963
SPAT1254
SPAT
Administration of medicine
2.2
6.1
61
297
N05AX08
ATC
risperidone; systemic
2.7
6.1
40
158
M79.6
ICD-10 Finland
Pain in limb
1.8
6.1
118
743
R39.1
ICD-10 Finland
Other difficulties with micturition
5.3
6.1
17
33
N03AX12
ATC
gabapentin; oral
2.3
6.0
56
264
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
209
1173
2.35
18.53
5.3
3.0
—
—
—
0
0
241
1475
2.23
16.97
6.5
3.9
—
—
—
0
0
305
2066
2.23
16.51
8.0
5.8
7.1
6.9
mmol/l
0.75
292
1957
284
1903
2.15
15.37
6.5
3.2
30.3
2994.1
e6/l
—
6
24
85
354
2.69
13.93
5.2
4.2
2.0
1.6
mmol/l
0.44
71
277
351
2612
2.17
13.73
10.1
8.4
78.2
81.1
u/l
0.73
327
2462
105
503
2.38
12.76
9.7
9.2
103.9
104.4
mmol/l
0.39
99
492
228
1477
2.00
12.74
7.4
5.6
33.7
35.6
g/l
3.54
211
1371
158
896
2.12
12.72
5.2
2.8
0.6
0.5
e6/l
0.01
122
684
150
836
2.14
12.62
3.6
2.6
—
—
—
0
0
107
523
2.33
12.39
4.0
2.5
1.1
0.4
e6/l
1.04
58
290
262
1794
1.97
12.36
8.0
7.4
13.5
13.0
umol/l
0.14
249
1714
278
1947
1.97
12.23
10.6
10.1
5.0
4.3
e9/l
2.99
248
1701
113
583
2.21
11.43
2.2
1.8
—
—
—
0
0
238
1613
1.91
11.23
11.7
8.3
1.2
1.2
mmol/l
0.63
206
1375
105
536
2.22
10.86
3.4
2.8
11.8
13.7
umol/l
1.67
97
505
220
1479
1.87
10.42
10.8
7.7
1.2
1.2
mmol/l
1.15
201
1359
118
641
2.10
10.38
4.1
3.8
0.8
0.8
mmol/l
2.78
111
610
106
555
2.16
10.25
3.9
2.4
1.4
0.8
e6/l
0.90
58
321
97
491
2.21
10.20
24.7
24.6
1.3
1.4
inr
0.10
17
67
59
242
2.63
9.87
2.4
1.8
—
—
—
0
0
17
29
6.03
9.65
1.8
1.6
—
—
—
0
0
97
505
2.14
9.46
3.5
2.7
2.2
2.3
g/l
0.17
91
472
134
787
1.96
9.40
2.6
2.0
3.3
3.0
mg/l
0.51
123
675
92
475
2.15
9.15
3.5
2.8
23.6
24.3
%
0.13
81
426
118
676
1.98
8.84
4.2
3.2
1.0
1.0
kg/l
1.27
17
86
82
410
2.20
8.83
2.0
1.7
—
—
—
0
0
164
1048
1.84
8.81
3.6
3.0
61.0
57.9
u/l
0.40
154
988
88
454
2.14
8.75
10.0
10.9
1.3
0.9
mmol/l
0.48
69
349
82
412
2.19
8.72
2.0
1.8
—
—
—
0
0
87
456
2.10
8.29
10.0
10.9
11.1
12.1
kpa
1.08
82
438
105
600
1.95
7.85
1.9
1.7
1192.2
1115.4
nmol/l
0.25
80
475
209
1475
1.72
7.79
4.7
2.8
0.0
0.0
estimate
0.00
27
240
42
165
2.69
7.65
2.4
2.1
4.0
0.9
ug/l
0.74
36
146
191
1323
1.72
7.56
2.2
2.0
86.7
90.7
pmol/l
0.67
112
759
210
1495
1.70
7.51
4.7
2.8
0.1
0.0
estimate
0.48
24
233
167
1119
1.74
7.42
2.6
2.2
69.7
72.8
nmol/l
0.64
145
990
84
453
2.03
7.38
4.3
4.3
221.4
247.6
u/l
1.62
79
429
407
3488
1.92
7.29
29.7
14.8
35.6
28.2
mg/l
3.53
363
2766
207
1479
1.68
7.23
6.3
3.8
0.0
0.0
estimate
0.00
29
256
173
1180
1.71
7.17
3.8
3.8
34.1
38.3
u/l
0.51
164
1123
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
137
2.75
6.97
2.7
2.8
0.3
0.3
u/ml
0.68
20
71
155
1037
1.72
6.83
2.5
2.2
348.0
342.5
u/l
0.01
145
965
73
385
2.05
6.80
2.3
2.6
0.2
0.2
g/l
0.43
65
352
24
73
3.40
6.78
1.5
1.2
—
—
—
0
0
24
73
3.40
6.78
1.5
1.2
—
—
—
0
0
27
89
3.15
6.72
2.3
1.3
—
—
—
0
0
301
2405
1.64
6.53
4.5
3.7
14.5
11.9
mm/h
1.57
282
2222
56
271
2.20
6.50
3.2
3.2
59.9
69.6
ml/min/173m2
1.18
28
110
151
1018
1.69
6.41
3.3
3.1
1693.2
1618.1
ng/l
0.09
138
878
123
788
1.75
6.26
5.0
3.0
0.0
0.0
estimate
0.68
26
224
46
208
2.34
6.26
1.7
1.4
—
—
—
0
0
349
2914
1.66
6.18
4.2
3.5
1.9
2.0
mu/l
0.26
322
2637
57
288
2.11
5.94
1.3
3.2
65.5
66.5
g/l
0.33
47
264
164
1150
1.64
5.91
5.0
2.9
—
—
—
0
0
280
2241
1.57
5.69
3.3
2.9
15.0
14.8
pmol/l
0.34
248
2016
165
1174
1.61
5.54
3.6
2.6
175.3
218.4
ug/l
0.91
153
1079
53
273
2.05
5.25
2.2
2.2
—
—
—
0
0
146
1020
1.61
5.24
4.4
3.6
2.3
2.3
mmol/l
0.19
128
897
185
1381
1.54
4.94
4.5
3.5
58.7
53.1
ng/l
0.10
143
989
107
701
1.67
4.93
4.8
3.8
262.6
602.8
ng/l
1.19
88
577
105
685
1.68
4.91
1.7
1.7
1.7
1.4
mg/l
0.16
82
517
20
67
3.07
4.88
1.4
1.4
124.3
89.6
u/ml
—
6
13
56
304
1.95
4.81
2.3
2.2
—
—
—
0
0
22
80
2.83
4.67
1.4
1.1
—
—
—
0
0
39
187
2.18
4.66
1.6
1.8
1.5
1.5
g/l
0.01
34
164
104
686
1.65
4.65
1.8
1.7
443.2
16525107.8
pmol/l
0.79
86
587
64
373
1.82
4.43
5.0
3.0
—
—
—
0
0
21
78
2.77
4.30
1.5
1.2
363.3
207.1
u/ml
0.84
13
43
22
84
2.69
4.29
1.8
1.9
—
—
—
0
0
409
3675
1.64
4.25
32.4
17.4
4.0
4.0
mmol/l
0.30
398
3583
69
417
1.76
4.24
2.1
3.0
11.9
10.3
umol/l
0.15
62
375
406
3655
1.61
4.03
32.5
17.3
139.1
139.6
mmol/l
3.91
395
3566
297
2511
1.45
3.98
4.5
3.3
66.3
60.7
u/l
0.46
278
2361
43
229
1.96
3.92
1.7
1.6
—
—
—
0
0
59
349
1.78
3.90
2.3
2.3
6.7
10.3
ug/l
0.89
51
310
151
1129
1.48
3.83
5.6
4.1
11.1
10.9
mg/mmol
0.02
104
800
32
156
2.12
3.70
2.5
2.6
351.1
606.0
ug/l
0.42
32
151
22
91
2.48
3.69
8.5
5.8
147.4
2154.0
iu/ml
—
5
14
28
131
2.21
3.59
2.1
1.8
—
—
—
0
0
40
218
1.91
3.43
6.3
3.6
1.2
1.2
mmol/l
0.05
35
197
23
102
2.32
3.34
3.3
1.5
—
—
—
0
0
330
2895
1.42
3.29
31.2
17.6
14.2
13.7
%
5.48
324
2812
103
735
1.51
3.23
1.7
1.6
15.1
19.1
nmol/l
3.53
91
627
29
144
2.08
3.22
2.4
2.0
—
—
—
0
0
52
314
1.73
3.22
2.8
3.0
198.9
225.0
ng/l
0.25
45
278
254
2140
1.38
3.17
2.8
2.7
—
—
—
0
0
379
3425
1.45
3.08
4.9
4.3
6.4
6.1
mmol/l
2.04
352
3120
19
81
2.40
3.02
1.6
1.6
—
—
—
0
0
14
51
2.80
3.01
1.1
1.6
—
—
—
0
0
276
2370
1.37
3.00
4.7
4.1
2.9
2.1
ug/l
0.62
252
2086
417
3853
1.51
2.89
13.9
10.3
29.7
31.7
u/l
1.39
407
3728
55
348
1.65
2.89
2.2
2.6
27.4
181.3
u/l
0.59
48
302
6
9
6.73
2.87
1.2
1.0
—
—
—
0
0
365
3295
1.41
2.83
7.3
5.7
42.2
40.3
mmol/mol
2.32
335
3065
24
117
2.10
2.82
2.7
2.2
67.5
117.4
ug/min
0.67
19
70
19
84
2.31
2.80
1.3
1.2
—
—
—
0
0
129
988
1.41
2.78
3.7
2.8
395.6
6364.9
umol/l
3.17
113
873
19
85
2.28
2.74
1.3
1.2
—
—
—
0
0
14
57
2.50
2.47
1.3
1.5
—
—
—
0
0
367
3348
1.37
2.43
23.8
13.0
83.1
82.5
ml/min/173m2
0.16
314
2801
25
133
1.93
2.35
1.1
3.0
—
—
—
0
0
25
133
1.93
2.35
1.1
3.0
7.3
7.0
g/l
0.33
18
99
25
133
1.93
2.35
1.1
3.0
4.4
3.9
g/l
0.46
18
94
24
126
1.95
2.35
1.1
3.2
3.0
3.1
g/l
0.27
18
96
41
256
1.66
2.29
4.4
4.0
2.3
1.6
mmol/l
0.65
32
200
13
53
2.49
2.29
1.3
1.5
—
—
—
0
0
23
122
1.93
2.20
1.1
3.1
11.4
10.9
g/l
0.13
18
102
15
67
2.28
2.19
1.3
1.6
—
—
—
0
0
18
87
2.11
2.19
1.9
1.6
260.5
264.2
ug/g
0.03
13
51
81
599
1.42
2.11
3.6
3.4
2.5
2.4
mmol/l
0.49
69
524
5
10
5.04
2.07
1.6
2.2
42.6
23.6
%
—
5
10
14
63
2.26
2.02
2.3
3.5
57.7
58.0
%
0.02
14
63
11
44
2.53
2.02
2.0
3.5
—
—
—
0
0
8
26
3.11
2.02
1.0
1.0
—
—
—
0
0
22
119
1.89
2.00
1.7
4.2
60.8
57.7
mg/l
0.06
16
101
22
119
1.89
2.00
1.6
4.2
30.3
37.3
mg/l
0.57
16
102
5
11
4.58
1.94
1.0
1.3
—
—
—
0
0
80
601
1.39
1.91
1.2
1.2
0.6
1.3
u/ml
3.05
19
162
78
587
1.39
1.85
3.1
2.1
1.9
1.6
%
1.69
71
512
359
3339
1.27
1.61
28.3
15.5
40.4
41.3
%
1.04
263
2466
212
1860
1.24
1.60
4.2
3.5
22.0
21.6
%
0.13
93
780
426
4054
1.36
1.59
38.4
20.6
135.7
142.0
g/l
9.24
419
3984
6
20
3.02
1.58
2.8
2.4
—
—
—
0
0
60
445
1.40
1.56
1.4
1.4
—
—
—
0
0
16
85
1.91
1.56
1.9
2.0
—
—
—
0
0
22
130
1.72
1.55
1.5
1.2
—
—
—
0
0
8
33
2.45
1.54
1.9
3.3
—
—
—
0
0
7
27
2.61
1.52
1.6
1.3
—
—
—
0
0
16
87
1.87
1.47
1.5
1.7
—
—
—
0
0
5
16
3.15
1.44
17.4
11.3
0.8
0.6
mmol/l
—
5
16
6
22
2.75
1.44
1.3
1.3
—
—
—
0
0
6
22
2.75
1.44
1.3
1.3
—
—
—
0
0
22
134
1.67
1.41
1.5
1.4
—
—
—
0
0
10
46
2.20
1.40
2.0
1.3
9255.8
112748.3
e6/l
—
5
29
25
158
1.61
1.40
2.2
3.1
—
—
—
0
0
7
29
2.43
1.39
1.0
1.1
—
—
—
0
0
6
23
2.63
1.37
5.7
1.5
—
—
—
0
0
6
23
2.63
1.37
5.7
1.5
—
—
—
0
0
380
3587
1.25
1.33
4.8
4.3
4.4
4.5
mmol/l
0.59
347
3345
9
43
2.11
1.31
1.9
2.3
—
—
—
0
0
5
18
2.80
1.29
1.0
1.0
124.2
181.6
iu/ml
—
5
18
8
36
2.24
1.24
1.3
1.2
—
—
—
0
0
12
63
1.93
1.23
2.2
3.3
3.9
4.5
e9/l
0.31
12
63
5
19
2.65
1.22
1.0
1.4
—
—
—
0
0
10
50
2.02
1.17
1.3
1.6
—
—
—
0
0
54
415
1.34
1.17
13.5
7.5
—
—
—
0
0
15
87
1.75
1.16
1.9
1.9
—
—
—
0
0
13
72
1.83
1.16
1.3
1.1
—
—
—
0
0
12
65
1.87
1.14
3.3
2.8
—
—
—
0
0
384
3650
1.23
1.14
5.2
4.7
2.7
2.7
mmol/l
0.39
353
3371
376
3567
1.22
1.13
4.8
4.2
1.2
1.3
mmol/l
5.32
346
3289
13
73
1.80
1.12
1.4
1.7
—
—
—
0
0
67
535
1.29
1.11
2.2
2.3
12.0
13.8
nmol/l
1.19
59
479
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
5
21
2.39
1.09
1.2
1.4
—
—
—
0
0
8
41
1.97
1.09
1.0
1.0
—
—
—
0
0
8
41
1.97
1.09
2.0
2.4
—
—
—
0
0
13
74
1.78
1.07
1.2
1.1
—
—
—
0
0
5
22
2.29
1.03
6.6
1.5
—
—
—
0
0
5
22
2.29
1.03
6.6
1.5
—
—
—
0
0
9
48
1.89
1.01
1.2
1.1
—
—
—
0
0
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
365
3471
1.19
0.98
4.5
3.9
1.5
1.4
mmol/l
2.09
336
3191
19
124
1.55
0.98
1.2
1.2
84.5
121.7
iu/ml
—
6
46
20
134
1.51
0.93
1.0
1.0
—
—
—
0
0
11
63
1.76
0.90
1.8
2.0
—
—
—
0
0
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
14
90
1.57
0.79
1.3
1.4
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
12
75
1.61
0.75
3.7
2.9
—
—
—
0
0
5
25
2.01
0.73
1.4
1.4
—
—
—
0
0
12
76
1.59
0.72
2.2
1.6
—
—
—
0
0
52
428
1.24
0.72
1.3
1.2
17.0
45.7
iu/ml
2.03
24
131
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
49
407
1.23
0.64
1.3
1.2
13.2
11.9
u/ml
0.05
19
167
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
6
37
1.63
0.55
1.3
1.1
—
—
—
0
0
6
38
1.59
0.54
1.2
1.8
—
—
—
0
0
6
40
1.51
0.51
1.3
1.7
—
—
—
0
0
46
393
1.19
0.48
4.8
4.2
30.6
29.9
%
0.14
26
264
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
10
69
1.46
0.44
1.2
1.2
—
—
—
0
0
16
122
1.32
0.43
6.4
3.0
1.9
1.6
mg/l
0.70
16
112
40
342
1.18
0.42
3.6
5.0
22.9
40.5
ug/l
0.29
34
297
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
16
0.00
0.41
0.0
1.4
—
156.5
—
0
16
0
17
0.00
0.40
0.0
1.7
—
207.1
—
0
17
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
5
34
1.48
0.40
2.4
2.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
12.9
—
0
11
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
97
891
1.11
0.38
1.7
1.7
1.6
1.5
mmol/l
0.67
83
757
6
42
1.43
0.35
2.0
4.2
—
—
—
0
0
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
141
1332
1.08
0.31
3.0
2.5
1.0
0.7
ug/l
0.60
87
781
10
75
1.34
0.30
1.5
1.2
—
—
—
0
0
8
66
1.22
0.27
1.9
1.3
—
—
—
0
0
5
39
1.28
0.23
1.4
1.4
473430.0
74771.9
e6/l
—
5
33
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.3
—
89.2
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
8
101
0.79
0.21
1.4
1.5
—
—
—
0
0
6
48
1.25
0.20
1.2
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
24
212
1.14
0.20
1.6
1.8
45.3
37.5
nmol/l
0.82
24
203
6
51
1.18
0.19
1.7
1.1
—
—
—
0
0
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
32
352
0.90
0.18
1.7
1.8
—
—
—
0
0
7
61
1.15
0.17
6.0
5.0
236.4
340.5
umol/l
—
7
53
5
45
1.11
0.10
3.6
3.8
2.3
7.0
nmol/l
—
5
45
16
146
1.10
0.08
1.5
1.6
—
—
—
0
0
7
68
1.03
0.08
1.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
9.7
—
0
8
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
1.3
—
0
6
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
110.3
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
0.00
2.6
4.5
50.3
283.4
u/ml
—
8
73
0
8
0.00
0.00
0.0
1.8
—
85.3
—
0
8
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_INFLAMALEGEN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_INFLAMALEGEN | 2.512 [2.08, 3.03] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 722 out of 2965 males with N14_INFLAMALEGEN died.
Mortality risk
Mortality risk for people of age
years, who have N14_INFLAMALEGEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.608% |
| 5 | No data | 3.211% |
| 10 | No data | 7.611% |
| 15 | No data | 14.331% |
| 20 | No data | 23.47% |
Relationships between endpoints
↥Index endpoint: N14_INFLAMALEGEN – Inflammatory disorders of male genital organs, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data